Modeling of the Bacterial Mechanism of Methicillin-Resistance by a Systems Biology Approach

Background A microorganism is a complex biological system able to preserve its functional features against external perturbations and the ability of the living systems to oppose to these external perturbations is defined “robustness”. The antibiotic resistance, developed by different bacteria strains, is a clear example of robustness and of ability of the bacterial system to acquire a particular functional behaviour in response to environmental changes. In this work we have modeled the whole mechanism essential to the methicillin-resistance through a systems biology approach. The methicillin is a β-lactamic antibiotic that act by inhibiting the penicillin-binding proteins (PBPs). These PBPs are involved in the synthesis of peptidoglycans, essential mesh-like polymers that surround cellular enzymes and are crucial for the bacterium survival. Methodology The network of genes, mRNA, proteins and metabolites was created using CellDesigner program and the data of molecular interactions are stored in Systems Biology Markup Language (SBML). To simulate the dynamic behaviour of this biochemical network, the kinetic equations were associated with each reaction. Conclusions Our model simulates the mechanism of the inactivation of the PBP by methicillin, as well as the expression of PBP2a isoform, the regulation of the SCCmec elements (SCC: staphylococcal cassette chromosome) and the synthesis of peptidoglycan by PBP2a. The obtained results by our integrated approach show that the model describes correctly the whole phenomenon of the methicillin resistance and is able to respond to the external perturbations in the same way of the real cell. Therefore, this model can be useful to develop new therapeutic approaches for the methicillin control and to understand the general mechanism regarding the cellular resistance to some antibiotics.

[1]  M. Devocelle,et al.  A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA). , 2008, Journal of theoretical biology.

[2]  H. Zhang,et al.  A Proteolytic Transmembrane Signaling Pathway and Resistance to β-Lactams in Staphylococci , 2001, Science.

[3]  Nicolas Guex,et al.  A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. , 2008, The Journal of infectious diseases.

[4]  M Abbott,et al.  Methicillin-resistant Staphylococcus aureus from Europe. , 1992, The Journal of hospital infection.

[5]  A. Voss,et al.  Methicillin-resistant Staphylococcus aureus in Europe. , 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[6]  P. Taylor,et al.  Methicillin Resistance in Staphylococcus Aureus: Mechanisms and Modulation , 2002, Science progress.

[7]  M. Sachdeva,et al.  Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. , 1994, The Biochemical journal.

[8]  F. Lowy,et al.  Pathogenesis of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Olsen,et al.  Severe Necrotizing Fasciitis in a Human Immunodeficiency Virus-Positive Patient Caused by Methicillin-Resistant Staphylococcus aureus , 2008, Journal of Clinical Microbiology.

[10]  S. Fridkin,et al.  Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Haley,et al.  Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. , 1995, The Journal of infectious diseases.

[12]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[13]  S. Rehm Staphylococcus aureus: the new adventures of a legendary pathogen. , 2008, Cleveland Clinic journal of medicine.

[14]  Hiroaki Kitano,et al.  CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .

[15]  J. Lehár,et al.  High-order combination effects and biological robustness , 2008, Molecular systems biology.

[16]  Sarah M. Keating,et al.  Evolving a lingua franca and associated software infrastructure for computational systems biology: the Systems Biology Markup Language (SBML) project. , 2004, Systems biology.

[17]  Outi Lyytikäinen,et al.  Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002 , 2004, Emerging infectious diseases.

[18]  Andreas Zell,et al.  SBMLsqueezer: A CellDesigner plug-in to generate kinetic rate equations for biochemical networks , 2008, BMC Systems Biology.

[19]  S. Meroueh,et al.  Resistance to β-Lactam Antibiotics and Its Mediation by the Sensor Domain of the Transmembrane BlaR Signaling Pathway in Staphylococcus aureus * 210 , 2003, The Journal of Biological Chemistry.

[20]  W. Craig,et al.  Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. , 1993, The Journal of antimicrobial chemotherapy.

[21]  M. Tewari,et al.  The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative? , 2006, PLoS medicine.

[22]  D. S. Henderson,et al.  The ORFeome of Staphylococcus aureus v 1.1 , 2008, BMC Genomics.

[23]  P. Giesbrecht,et al.  Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin , 1998, Microbiology and Molecular Biology Reviews.

[24]  Marc Vidal,et al.  ORFeome cloning and systems biology: standardized mass production of the parts from the parts-list. , 2004, Genome research.

[25]  G. Harding,et al.  The Postantibiotic Effect: A Review of in Vitro and in Vivo Data , 1991, DICP : the annals of pharmacotherapy.

[26]  Roland R. Regoes,et al.  Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens , 2004, Antimicrobial Agents and Chemotherapy.

[27]  S. Costantini,et al.  On new challenge for the Bioinformatics , 2008, Bioinformation.

[28]  A. Voss,et al.  Methicillin-ResistantStaphylococcus aureus in Europe , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[29]  B. Robinson-Dunn,et al.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. , 1999, The New England journal of medicine.

[30]  F. Lowy Antimicrobial resistance: the example of Staphylococcus aureus. , 2003, The Journal of clinical investigation.

[31]  P. L. Mitchell,et al.  Systems biology or the biology of systems: routes to reducing hunger. , 2008, The New phytologist.

[32]  M. Savic,et al.  Critical Residues for Cofactor Binding and Catalytic Activity in the Aminoglycoside Resistance Methyltransferase Sgm , 2008, Journal of bacteriology.

[33]  M. Lipsitch,et al.  Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Teruyo Ito,et al.  Staphylococcal Cassette Chromosome mec (SCCmec) Typing of Methicillin-Resistant Staphylococcus aureus Strains Isolated in 11 Asian Countries: a Proposal for a New Nomenclature for SCCmec Elements , 2006, Antimicrobial Agents and Chemotherapy.